<- Go Home
CareFusion Corporation
CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, and respiratory care. The company operates through two segments, Medical Systems and Procedural Solutions. Its primary product brands include Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela, and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite, and Texium needle-free IV infusion valves, and administration sets and accessories; PleurX, Achieve, and Temno interventional specialty products; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Jaeger and SensorMedics cardiopulmonary diagnostic equipment; Vital Signs single-use consumables for respiratory care and anesthesiology; and MedMined data mining surveillance software and analytics tools to help hospitals identify adverse drug events and healthcare associated infections. The company also offers CareFusion branded ventilation system; and Guardrails, a software application. Its primary customers include hospitals, ambulatory surgical centers, clinics, long-term care facilities, and physician offices in the United States. The company also sells its products to hospitals in approximately 130 countries. It offers its products directly to group purchasing organizations, as well as through integrated delivery networks, wholesalers, and distributors. The company was incorporated in 2009 and is based in San Diego, California.CareFusion Corporation operates as a subsidiary of Becton, Dickinson and Company.
Market Cap
$12.2B
Volume
2.0M
Cash and Equivalents
$1.8B
EBITDA
$928.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$2.0B
Profit Margin
49.28%
52 Week High
$60.40
52 Week Low
$37.76
Dividend
N/A
Price / Book Value
2.22
Price / Earnings
25.45
Price / Tangible Book Value
10.00
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$722.0M
Return on Equity
9.04%
Return on Assets
5.06
Cash and Short Term Investments
$1.8B
Debt
$2.0B
Equity
$5.5B
Revenue
$4.1B
Unlevered FCF
$771.3M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium